Retraining programme for older patients undergoing peritoneal dialysis: A randomised controlled trial

被引:4
作者
Leung, Wai Yin [1 ]
Ng, Marques S. N. [2 ]
Hau, Anthony K. C. [3 ]
So, Winnie K. W. [2 ]
机构
[1] Mt Sinai Hosp, New York, NY 10029 USA
[2] Chinese Univ Hong Kong, Hong Kong, Peoples R China
[3] Tuen Mun Hosp, Hong Kong, Peoples R China
关键词
chronic kidney failure; clinical trial; cost-benefit analysis; peritoneal dialysis; peritonitis; PREVENTION; IMPACT; KNOWLEDGE; 1ST;
D O I
10.1111/jorc.12450
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
BackgroundPeritonitis is a common cause of hospitalisation and death among patients undergoing peritoneal dialysis. Periodic retraining is recommended to prevent peritonitis, especially in older adults. ObjectivesWe evaluated the effectiveness of a retraining programme for reducing peritonitis and exit site infection rates in older adults on peritoneal dialysis. The cost-benefit ratio was also calculated. DesignA two-arm prospective randomised controlled trial. ParticipantsOne hundred and thirty patients aged 55 years or older were recruited. Participants were randomly assigned to the intervention or control group. While both groups received usual care, the intervention group received a retraining programme (a knowledge and practical assessment and a one-on-one retraining session) 90 days after starting home-based continuous ambulatory peritoneal dialysis therapy. MeasurementsThe outcomes included peritonitis rate, exit site infection rate and direct medical costs at 180, 270, and 360 days after starting home-based continuous ambulatory peritoneal dialysis therapy. ResultsNo significant differences were found in the baseline characteristics between groups. The peritonitis rates were 0.11 episodes per patient-year in the intervention group versus 0.13 in the control group. The incidence of exit site infection was 20.0% in the intervention group and 12.3% in the control group. The cost-benefit ratio of retraining was 1:9.6. None of the results were statistically significant. ConclusionsThe absence of statistical significance may be partly explained by the premature termination of the study. Large-scale multi-centre trials are warranted to examine the effectiveness of retraining. The timing and long-term effects of retraining also need to be examined.
引用
收藏
页码:253 / 263
页数:11
相关论文
共 50 条
  • [1] Retraining for prevention of peritonitis in peritoneal dialysis patients: A randomized controlled trial
    Ljungman, Susanne
    Jensen, Jorgen E.
    Paulsen, Dag
    Petersons, Aivars
    Ots-Rosenberg, Mai
    Saha, Heikki
    Struijk, Dirk G.
    Wilkie, Martin
    Heimburger, Olof
    Stegmayr, Bernd
    Elung-Jensen, Thomas
    Johansson, Ann-Cathrine
    Rydstrom, Margareta
    Gudmundsdottir, Helga
    Petzold, Max
    PERITONEAL DIALYSIS INTERNATIONAL, 2020, 40 (02): : 141 - 152
  • [2] Roxadustat treatment for anemia in peritoneal dialysis patients: A randomized controlled trial
    Hou, Yan-Pei
    Mao, Xin-Yue
    Wang, Chang
    Xu, Zhi-Hui
    Bu, Zhi-Hua
    Xu, Meng
    Li, Bing
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2022, 121 (02) : 529 - 538
  • [3] Prevalence of chronic periodontitis in patients undergoing peritoneal dialysis and its correlation with peritoneal dialysis-related complications
    Chen, Zhihao
    Deng, Hai
    Sun, Kristine
    Huang, Zehui
    Wei, Shan
    Lin, Yunyao
    Song, Zhongchen
    Liu, Yingli
    BMC NEPHROLOGY, 2023, 24 (01)
  • [4] Application of instant messaging software in the follow-up of patients using peritoneal dialysis, a randomised controlled trial
    Cao, Fang
    Li, Lanfei
    Lin, Miao
    Lin, Qinyu
    Ruan, Yiping
    Hong, Fuyuan
    JOURNAL OF CLINICAL NURSING, 2018, 27 (15-16) : 3001 - 3007
  • [5] Neuropsychological impairments in patients undergoing peritoneal dialysis treatment
    Sanchez-Fernandez, Maria del Mar
    del Paso, Gustavo A. Reyes
    Quiros-Ganga, Pedro L.
    Moreno-Salazar, Antonio S.
    Fernandez-Serrano, Maria Jose
    MEDICINA CLINICA, 2024, 162 (04): : 147 - 156
  • [6] Pasteurella multocida peritonitis in patients undergoing peritoneal dialysis
    LoghmanAdham, M
    PEDIATRIC NEPHROLOGY, 1997, 11 (03) : 353 - 354
  • [7] kuPasteurella multocida peritonitis in patients undergoing peritoneal dialysis
    Mahmoud Loghman-Adham
    Pediatric Nephrology, 1997, 11 : 353 - 354
  • [8] Dialysis headache in patients undergoing peritoneal dialysis and hemodialysis
    Stojimirovic, Biljana
    Milinkovic, Marija
    Zidverc-Trajkovic, Jasna
    Trbojevic-Stankovic, Jasna
    Maric, Ivko
    Milic, Miodrag
    Andric, Branislav
    Nikic, Petar
    RENAL FAILURE, 2015, 37 (02) : 241 - 244
  • [9] Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH)
    de Moraes, Thyago Proenca
    Cruz Andreoli, Maria Claudia
    Canziani, Maria Eugenia
    da Silva, Dirceu Reis
    Teixeira Caramori, Jacqueline Costa
    Ponce, Daniela
    Cassi, Helio Vida
    Bastos, Kleyton de Andrade
    Alves Rio, Danyelle Romana
    Pinto, Sergio Wyton
    Ferreira Filho, Sebastiao Rodrigues
    de Campos, Ludimila Guedim
    Olandoski, Marcia
    Divino-Filho, Jose Carolino
    Pecoits-Filho, Roberto
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30 (11) : 1905 - 1911
  • [10] Oral vitamin D supplementation on the prevention of peritoneal dialysis-related peritonitis: A pilot randomised controlled trial
    Zhang, Yu-Hui
    Xu, Xiao
    Pi, Hai-Chen
    Yang, Zhi-Kai
    Johnson, David W.
    Dong, Jie
    PERITONEAL DIALYSIS INTERNATIONAL, 2024, 44 (01): : 27 - 36